Daratumumab Confirmed as SOC for AL AmyloidosisDecember 17, 2024Multiple MyelomaBleeding DisordersMixed TopicsASH 2024
Upfront Therapy for ITP in Children: New Drug a Game-Changer?December 17, 2024Bleeding DisordersThrombosisPediatricsASH 2024
Multiple Myeloma: Dexamethasone-Sparing Approach Benefits Frail Older AdultsDecember 13, 2024Multiple MyelomaPatient & Survivor CareASH 2024
Do GLP-1s Lower VTE Risk in People With Type 2 Diabetes?December 12, 2024ThrombosisMixed TopicsASH 2024
Fertility Preservation in SCD: Women Have More ComplicationsDecember 11, 2024Bleeding DisordersAnemiaMixed TopicsASH 2024
Does Acalabrutinib Fit Into Frontline MCL Therapy?December 11, 2024Mantle Cell LymphomaB Cell LymphomaASH 2024
POLARIX: Extended Results Confirm Standard of Care for DLBCLDecember 11, 2024DLBCLNon-Hodgkin LymphomaASH 2024
Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune ThrombocytopeniaDecember 10, 2024Bleeding DisordersThrombosisASH 2024
Epcore NHL-1 Update: Treatment Effective Before CAR TDecember 10, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaCellular TherapyASH 2024
High-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD OutcomesDecember 9, 2024TransplantPatient & Survivor CareALLCLLNon-Hodgkin LymphomaMyelodysplastic SyndromeMixed Topics
24-Hour Urine Testing in Multiple Myeloma: Time to Stop?December 9, 2024Multiple MyelomaPatient & Survivor CareASH 2024
